Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.990
+0.060 (3.11%)
At close: Dec 5, 2025, 4:00 PM EST
2.000
+0.010 (0.50%)
After-hours: Dec 5, 2025, 7:10 PM EST
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $75.15 million as of December 5, 2025. Its market cap has increased by 144.10% in one year.
Market Cap
75.15M
Enterprise Value
73.53M
1-Year Change
144.10%
Ranking
Category
Stock Price
$1.99
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $75.15M, an increase of 4,127.81%. That is a compound annual growth rate of 230.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 75.15M | 73.11% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |